top of page

AI May Help Predict PAH Patients' Risk of Worsening

Researchers looked at the medical records of 455 people with pulmonary arterial hypertension (PAH) to find factors associated with getting worse. Using a machine-learning computer model, they found 11 clinical features linked to a higher chance of a worsening event, but only body mass index and red cell distribution width were statistically significantly associated with clinical worsening.


About half of the patients experienced a worsening event during the study, usually within about 11 months. The model was reasonably good at identifying patients at higher risk. The researchers suggest that using automated prediction tools like this could help doctors recognize problems earlier and adjust treatment sooner to improve patient outcomes.


 
 
 

Recent Posts

Sotatercept and cardiopulmonary comorbidities

This study from one clinic examined how well sotatercept worked in real-world patients with pulmonary arterial hypertension (PAH) who also had other heart or lung conditions, such as coronary artery d

 
 
 
Sotatercept vs. selexipag in severe PAH

Researchers used AI to indirectly compare data from three randomized controlled trials looking at sotatercept or selexipag in pulmonary arterial hypertension (PAH). Their findings suggest that sotater

 
 
 

Comments


PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Charitable Registration # 872050224RR0001

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe   |   Powered by raisin

bottom of page